The ANZCHOG Board provides oversight and strategic direction, ensuring the organisation’s growth, sustainability and relevance.
A/Prof Andy Moore
Chair
Queensland Children’s Hospital, Brisbane
Andy Moore is a senior staff specialist in paediatric oncology at the Queensland Children’s Hospital, working within the Leukaemia, Lymphoma and Bone Marrow Transplant Service. His clinical and research interests focus on leukaemia, particularly acute myeloid leukaemia (AML). He has a PhD in preclinical drug development for AML from The Institute of Cancer Research (University of London) and is Clinical Director of the Queensland Children’s Tumour Bank. Andy also has a number of research leadership roles, including being Director of Research at Children’s Health Queensland Hospital & Health Service. Andy joined the ANZCHOG Board of Directors as Deputy Chair in 2020 and was appointed Chair in 2025.
Dr Neevika Manoharan
Deputy Chair
Sydney Children’s Hospital, Sydney
Dr Neevika Manoharan is a Paediatric Haematologist/Oncologist and subspecialist Paediatric Neuro-Oncologist based at the Kids Cancer Centre at Sydney Children’s Hospital. Dr Manoharan returned to a Staff Specialist position at the Kids Cancer Centre after completing a coveted Fellowship in Paediatric Neuro-Oncology at Dana-Farber Cancer Institute, Boston Children’s Hospital and Harvard Medical School in 2019. Neevika joined the ANZCHOG Board of Directors in 2023.
Prof Nick Gottardo
Immediate Past Chair
Perth Children’s Hospital, Perth
Nick Gottardo is a paediatric oncologist/neuro-oncologist and Head of the Department of Paediatric Oncology and Haematology at Perth Children’s Hospital. He is also the Co-leader of the Brain Tumour Research Programme at the Telethon Kids Institute. He commenced as Chair of ANZCHOG in 2020 and was previously the Chair of ANZCHOG’s CNS Tumours Group.
Prof Deborah White
Treasurer
South Australian Health and Medical Research Institute, Adelaide
Professor Deb White is the Precision Medicine Theme Leader at the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide, and Group Leader of the Acute Lymphoblastic Leukaemia Genomics and Functional Genomics Research Group and is a Professor in The Faculties of Health and Medical Sciences and The Sciences at the University of Adelaide. Deb is a Board Director of the Australasian Leukemia Lymphoma Group (ALLG) and a member of the Lab Sciences Committee for ALLG and the Leukaemia/Lymphoma Group of ANZCHOG.
Dr Siobahn Cross
Director
Christchurch Hospital, Christchurch
Siobhan Cross is a Paediatric Haematologist/ Oncologist at the Children’s Haematology Oncology Centre at Christchurch Hospital, the current chair of the ANZCHOG Leukaemia Lymphoma Group and a member of the Children’s Oncology Group cancer control steering committee. She joined the ANZCHOG Board as the New Zealand representative in 2022.
Ms Rachel Edwards
Director
Queensland Children’s Hospital, Brisbane
Rachel Edwards is a Paediatric Oncology Research Nurse with research interests in symptom assessment and management, vascular access and staff wellbeing. In addition to this role, she is employed as the paediatric oncology nursing subject matter expert for EviQ Education, Cancer Institute NSW. In this role she is responsible for developing paediatric oncology curriculum and writing online learning content. Rachel has been the Chair of the ANZCHOG Nursing Sub-group for 8 years and is now representing the nursing membership on the ANZCHOG board.
Prof Jordan Hansford
Director
Women’s and Children’s Hospital, Adelaide
Jordan Hansford is a Clinical Paediatric Oncologist and children’s brain cancer specialist at the Women’s and Children’s Hospital, Program Leader in Paediatric Neuro-Oncology at the South Australian Health and Medical Research Institute and Affiliate Professor at South Australian Immuno-genomics Cancer Institute, University of Adelaide. Jordan joined the ANZCHOG Board of Directors in 2020 and also serves as Chair of ANZCHOG’s CNS Tumours Group.
Lucy Jones
Director
Lucy Jones is the CEO of Neuroblastoma Australia and mother to Sienna and Jamie Hoffmann.
Lucy is focused on driving change in survival rates through more research, having tragically lost her daughter Sienna to neuroblastoma in 2010. Lucy joined the ANZCHOG Board of Directors in 2024, having previously been involved with the organisation as an Associate Investigator on clinical trials and providing her lived experience perspective and knowledge she has acquired from liaising with many families affected by neuroblastoma.
Dr Maria Kirby
ANZCHOG Medical Director
Women’s and Children’s Hospital, Adelaide
Dr Maria Kirby is a Paediatric Oncologist at the Women’s and Children’s Hospital, Adelaide. She has a particular clinical interest in sarcomas and in neuro-oncology, while her research interests are in clinical trials. Dr Kirby is the ANZCHOG Medical Director.
Dr Kanika Bhatia
Director
Royal Children’s Hospital, Melbourne.
Dr Kanika Bhatia is a Paediatric Oncologist at the Children’s Cancer Centre, Royal Children’s Hospital (RCH), Melbourne. She also serves as Clinical Director of the Paediatric Integrated Cancer Service (PICS), where she provides leadership in cancer system reform and service improvement.
Her clinical and research interests include solid and brain tumours, paediatric cancer genetics, palliative care and supportive care. She is the clinical lead for a multidisciplinary paediatric cancer genetics program at RCH supporting families with cancer predisposition syndromes.
Dr Bhatia is also committed to education and workforce development with a focus on clinical training and pastoral care within the paediatric oncology community.